Erle T. Mast, Executive VP and CFO at Clovis Oncology, Inc. (CLVS), sold 3,000 shares at $81.00 ($245K) on 2015-05-01, disclosed to the SEC on 2015-05-05.
Scheduled sale ($245k) by Executive VP and CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $81.00 | 879 | $71K | 29.0% |
| 2 | $81.98 | 1,800 | $148K | 60.1% |
| 3 | $82.46 | 221 | $18K | 7.4% |
| 4 | $83.55 | 100 | $8K | 3.4% |
| Total | $81.78 avg | 3,000 | $245K | 100% |
| Filing → |
| SNNA | BUY | 2017-08-01 | $101K | — | Filing → |
| CLVS | SELL | 2015-11-03 | $317K | — | Filing → |
| CLVS | SELL | 2015-10-02 | $271K | — | Filing → |